Advertisement

Tirzepatide Dispensations Increased Rapidly After Approval

0

By December 2023, 12.3 percent of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM

Adverse Events From Semaglutide Seen in the ED Usually GI-Related

0

Most common gastrointestinal issues seen are nausea/vomiting, abdominal pain, and diarrhea

Heart Disease Mortality Increases With Combined Day-Night Heatwaves

0

Nonlinear curves found for daytime-only and nighttime-only heatwaves, while compound heatwaves linked to steady increase in mortality

New Definition of Epilepsy Improves Diagnosis, Treatment

0

Most newly diagnosed patients were seizure-free at 12 months of follow-up

Pfizer Ends Testing of Obesity Pill After Possible Liver Injury

0
By I. Edwards HealthDay Reporter TUESDAY, April 15, 2025 (HealthDay News) -- Pfizer has stopped developing a once-daily pill to treat obesity after a person...

American College of Physicians, April 3-5

0
By Beth Gilbert HealthDay Reporter The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New Orleans...

Climate Change Tied to Alterations in Pollen Seasons, Concentrations

0

Increase in allergic rhinitis-related health care reported in four studies, with low-income residents most impacted

Some Patients Charged Copays for Sending Messages Through Patient Portals

0

Study reveals Medicaid and private insurance copay rates are similar for adults 50 years and older using portal messaging

CDC Urges Extra Measles Shot for Some U.S. Travelers Amid Outbreak

0
By I. Edwards HealthDay Reporter FRIDAY, April 11, 2025 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention (CDC) now recommends extra measles...

Possible Fecal Contamination Prompts Butter Recall

0

Manufacturer has identified the cause of the issue and implemented the necessary internal actions to resolve it